Search PubMed⌕ Search

Biomedical subjects

F O Simpson

Publications and source records attributed to F O Simpson.

At least 91 records · Page 5Linked to original sources
PubMed1978

The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine.

This paper describes the methods and general aims of a survey carried out on just over 1200 subjects (about 82% of the adult population) in Milton, a small town south of Dunedin. Data were collected on personal and family history, present medication if any, 24-hour dietary recall, psychometric scores, height, weight, skin-fold thickness, anthropometry, blood pressure, heart rate, electrocardiogram, mass miniature X-ray of chest, forced expiratory volume (FEV1), fasting plasma cholesterol and triglycerides, lipoprotein pattern and fasting and post-prandial blood sugar in a selected subgroup, and 24-hour urine volume and excretion of sodium, potassium, calcium, magnesium and creatinine. Mean values are given in the paper for each 10-year age group for height, weight, Quetelet's index, 24-hour urine volume, creatinine, sodium, potassium, calcium and magnesium. These and other results will be discussed in detail in subsequent papers.

Adolescent↗
PubMed1978

Relationship of blood pressure to sodium excretion in a population survey.

1. Blood pressure, height, weight and 24 h urinary output of sodium, potassium and creatinine were measured in over 500 adults of each sex during a health survey of the population of a small town. 2. Both systolic and diastolic pressure were significantly related to Quetelet's index (weight/height2) and heart rate. 3. There was no significant relationship between blood pressure and output of sodium or potassium, sodium/potassium ratio or sodium/creatinine ratio.

Adolescent↗
PubMed1978

Effects of different diuretics on urinary calcium excretion in a general population.

Calcium excretion by users and non-users of thiazide diuretics and frusemide was studied during a health survey. Men taking thiazides excreted less calcium than age- and weight-matched controls. Both men and women taking thiazides excreted less calcium relative to sodium than controls. Women taking thiazides excreted significantly less calcium than women taking frusemide. Both men and women taking thiazides excreted less calcium relative to creatinine than sex-matched groups taking frusemide.

Adolescent↗
PubMed1977

Treatment of hypertension with labetalol.

Labetalol, a new antihypertensive drug which combines alpha- and beta-blocking properties, was used in an open clinical trial in a mixed group of 47 adult patients with mainly essential hypertension, many of whom had been poorly controlled on other drugs. Labetalol lowered lying and standing blood pressures significantly when given alone or when combined with other antihypertensive drugs and it was generally well tolerated. It is easy to use, and in some severe cases has been dramatically effective. Mean daily dose was 767 mg. A postural hypotensive effect was seen especially in patients taking concomitant diuretics but was not troublesome. Labetalol reduced heart rate in patients who were not on previous or concomitant beta-blocker therapy. Side effects were few and did not cause major problems. A transiently or persistently weakly positive ANF was noted in nine patients; the significance of this is uncertain at this stage and needs further assessment. Raynaud's phenomenon, which had complicated previous beta-blocker therapy in some patients, improved with labetalol.

Adult↗
PubMed1977

Use of prazosin at the dunedin hypertension clinic controlled and open studies and pharmacokinetic observations.

Prazosin has been used as an antihypertensive drug in the treatment of 93 patients in Dunedin since 1971-1972, mainly those whose previous control was unsatisfactory. It has led to very significant improvement of control in many cases; 48 patients now receiving the drug have taken it for an average of 30 months. Forty-five patients have stopped taking the drug for various reasons, such as failure to respond (11-8%), side effects (20-4%), myocardial infarction (8-6%) or unrelated reasons (7-5%). This reflects to some extent the use ofa new drug in patients who are difficult to control, and its use initially without concomitant diuretic and beta-blocker therapy. We believe that the place of praxosin is primarily as a third drug for patients whose hypertension does not respond satisfactorirly to a diuretic and a beta-blocker. The first dose must be kept small, preferably 0-25 mg, and even with this dose a small proportion of patients receiving diuretic and beta-blocker therapy seem to become hypotensive; patients should be warned about this. The plasma half-life in normal volunteers was 3-8 hours but in some patients it seems to be considerably longer.

Adrenergic beta-Antagonists↗
PubMed1976

Effects of prazosin in patients with hypertension.

A double-blind placebo crossover trail (2 periods, each of 6 wk) was carried out in 12 patients. In the first period the patients were randomly allocated to either their individual established dose of prazosin or to the same number of placebo tablets; treatment was reversed after 6 wk. Blood pressure was higher by 17/8 mm Hgin the lying posture and by 24/14 mm Hg in the standing posture during placebo than during prazosin treatment. Standing pulse rate and body weight were higher and plasma renin activity lower during prazosin treatment. Postural hypotension occurring 1 to 2 hr after the first few doses was noted in one third of the patients when they resumed prazosin treatment after the placebo course.

Adrenergic beta-Antagonists↗
PubMed1976

Discriminant function analysis of factors related to myocardial infarction in male patients on antihypertensive therapy.

Records of 367 male patients who began attending the Dunedin Hospital Hypertension Clinic between 1959 and 1969 were coded up to the end of 1972. Of these patients, 60 had their first myocardial infarction, or sudden cardiac death without previous evidence of myocardial infarction, while they were attending the clinic. This infarct group was compared with a control group of 120 which was chosen from the remaining patients so that the two groups would be comparable with regard to their age and year of first attendance. A stepwise discriminant function analysis showed that the basal systolic and diastolic pressures measured when patients started attending the clinic were the variables with the most significant difference. Further analysis showed that inclusion of the average casual standing systolic pressure when patients were receiving antihypertensive therapy improved the discrimination between the groups. The average casual standing diastolic pressure during antihypertensive therapy also improved the discrimination, but, curiously enough, with a negative sign in the discriminant function. Quetelet's index of obesity similarly improved the discrimination, obese subjects having less risk of infarction or sudden death. Serum cholesterol, however, was not related to prognosis.

Age Factors↗
PubMed1976

Experience with labetalol in hypertension.

1 The effect of labetalol has been assessed in an open clinical trial in 19 patients with sub-optimal control of blood pressure on other therapy, and in a placebo-controlled cross-over study. Most patients were taking a diuretic before the trial and they continued to do so during the trial. 2 In the open trial, labetalol successfully lowered blood pressure in most of the patients. Average daily dose was about 600 mg. The placebo-controlled trial confrimed the anti-hypertensive effect. 3 A clear postural hypotensive effect was seen. A few patients noted postural faintness as a side-effect, especially in a hot environment; but it was not troublesome. 4 There were few other side-effects. One patient experienced an increase in serum glumatic--oxalic transaminase (SGOT) and another an increasing anti-nuclear factor titre, but it is not yet certain that these were due to labetalol.

Adult↗
PubMed1975

Clonidine in menopausal flushing: a double-blind trial.

Twelve hypertensive women were treated with low doses of the antihypertensive drug clonidine for their menopausal flushing in a double-blind trial. There was a high degree of placebo effect but clonidine at a daily dose of 150mug was more effective than placebo.

Climacteric↗